Dyslipidemia Associated With Type II Diabetes Mellitus: Clinical Trials

13 trials for Dyslipidemia Associated With Type II Diabetes Mellitus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 4 Phase 4, 3 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Terminated 1
Not applicable3Active not recruiting 1, Recruiting 1, Unknown 1
Phase 32Recruiting 1, Unknown 1

Follow Dyslipidemia Associated With Type II Diabetes Mellitus: new trials by email Literature Review of Dyslipidemia Associated With Type II Diabetes Mellitus trials Research Report on Dyslipidemia Associated With Type II Diabetes Mellitus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Moderate-intensity statin monotherapy, Ezetimibe or ezetimibe-statin combination therapy - Dyslipidemia Associated With Type II Diabetes Mellitus
Not applicableRecruitingSin Gon Kim21862026-03-092026-03-10
Paraclinical Cardiometabolic Risk Assessment in Type 2 Diabetes
Dyslipidemia Associated With Type II Diabetes Mellitus
CompletedTokat Gaziosmanpasa University21882025-03-012026-01-23
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
BERLIM 25/20 ASSOCIATION, EMPAGLIFLOZIN PLACEBO, ROSUVASTATIN CALCIUM PLACEBO - Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 3RecruitingEMS2282023-12-012025-12-08
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Questionnaires+Tongue diagnosis+Pulse diagnosis - Diabete Mellitus, Pre-diabetes
CompletedSingapore Chung Hwa Medical Institution1712022-09-172025-05-04
Effectiveness of Nutritional Program Among Diabetic Patients
DASH diet - Dyslipidemia Associated With Type II Diabetes Mellitus
Not applicableUnknownAssiut University1902022-03-012021-11-22
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose, Atorvastatin (Lipitor ®) - Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 3UnknownLaboratorios Silanes S.A. de C.V.782022-02-152022-03-02
Dietary Strategies for Remission of Type 2 Diabetes
Energy restricted diet, Low carbohydrate high fat diet - Diabetes Mellitus, Type 2, Overweight and Obesity
Not applicableActive not recruitingUniversity of Bergen6002022-01-042026-10-02
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Chinese herb medicine - Type 2 Diabetes Mellitus in Obese, Dyslipidemia Associated With Type II Diabetes Mellitus
CompletedGuang'anmen Hospital of China Academy of Chinese Medical Sciences952021-10-272023-09-15
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Atorvastatin 40 Mg Oral Tablet - Diabetes Mellitus, Type 2, Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 4CompletedHopital La Rabta1042021-03-012023-04-10
EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial
Evolocumab 140 MG/ML - Dyslipidemia Associated With Type II Diabetes Mellitus, Diabetes Mellitus, Type 2
Phase 4CompletedUniversity of Campinas, Brazil1102018-10-012023-03-09
Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus
Evolocumab, Placebo - Diabetes Mellitus, Type 2, Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 4TerminatedInova Health Care Services42018-05-012023-01-19
Type 2 Diabetic Patients Maintained on Statin Therapy
Atorvastatin 40 Mg Oral Tablet, Rosuvastatin 10 Mg Oral Tablet - Dyslipidemia Associated With Type II Diabetes Mellitus
Phase 4CompletedDamanhour University1602018-01-012021-01-05
An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes
Pravastatin - Dyslipidemia Associated With Type II Diabetes Mellitus
CompletedDaiichi Sankyo29722016-01-202021-11-04

Narrower conditions

Diabetes Mellitus, Type 2 (11)  ·  Dyslipidemias (8)  ·  Hypertension (3)  ·  Diabetes Mellitus (2)  ·  Glucose Intolerance (2)  ·  Obesity (2)  ·  Adrenal Insufficiency (1)  ·  Eunuchism (1)  ·  Hypertriglyceridemia (1)  ·  Insulin Resistance (1)  ·  Overweight (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Endocrine System Diseases (12)  ·  Glucose Metabolism Disorders (12)  ·  Metabolic Diseases (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Diabetes Mellitus (10)  ·  Lipid Metabolism Disorders (8)  ·  Cardiovascular Diseases (3)  ·  Nutrition Disorders (3)  ·  Vascular Diseases (3)  ·  Body Weight (2)  ·  Hyperglycemia (2)  ·  Overnutrition (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Adrenal Gland Diseases (1)

Interventions

Atorvastatin (3)  ·  Rosuvastatin Calcium (2)  ·  Tablets (2)  ·  evolocumab (2)  ·  Dietary Approaches To Stop Hypertension (1)  ·  Ezetimibe (1)  ·  Fenofibrate (1)  ·  Pravastatin (1)  ·  empagliflozin (1)

Sponsors

Assiut University (1)  ·  Daiichi Sankyo (1)  ·  Damanhour University (1)  ·  EMS (1)  ·  Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1)  ·  Hopital La Rabta (1)  ·  Inova Health Care Services (1)  ·  Laboratorios Silanes S.A. de C.V. (1)  ·  Sin Gon Kim (1)  ·  Singapore Chung Hwa Medical Institution (1)  ·  Tokat Gaziosmanpasa University (1)  ·  University of Bergen (1)  ·  University of Campinas, Brazil (1)

Countries

Brazil (2)  ·  South Korea (2)  ·  China (1)  ·  Egypt (1)  ·  Mexico (1)  ·  Norway (1)  ·  Singapore (1)  ·  Tunisia (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Andrei C Sposito, MD,Phd (1)  ·  Bong-Soo Cha, MD (1)  ·  Francisco G Padilla Padilla, M.D (1)  ·  Jiaxing Tian, PhD (1)  ·  Juan A Peraza Zaldivar, M.D (1)  ·  Melika Chihaoui, Professor (1)  ·  Rehab Werida, Lecturer (1)  ·  Sin Gon Kim, MD (1)

Results publications

PMID 33062236, PMID 38764377, PMID 38880822, PMID 39265161, PMID 40323331